Control values of ovarian cancer tumor markers and standardisation of a protocol for sampling peritoneal fluid and performing washing during laparoscopy
Open Access
- 4 September 2014
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 12 (1) , 1-9
Abstract
Determination of the tumor marker concentration in peritoneal fluid (PF) may help to assess its potential to detect small concentration changes between benign ovarian pathology and early stage ovarian cancer. Peritoneal washing, which can also be obtained when PF is absent, is already included in the International Federation of Gynecology and Obstetrics (FIGO) staging classification for ovarian cancer but sampling has not yet been standardized. Since our aim was to evaluate the relationship between marker concentration in PF and washing, standardization of the sampling protocol was a prerequisite to ensure reliable results. Thirty-three women with non-malignant pathology of the reproductive organs were included in the study. We used three promising tumor markers for evaluation of the marker concentration in local fluid: osteopontin (sOPN), splice variant 6 of sCD44 (sCD44-v6) and vascular cell adhesion molecule-1 (sVCAM-1). After aspiration of PF, washing of the uterus, ovaries and pelvic peritoneum was performed with saline solution. Patients were divided into two groups based on the solution volume: A-20 ml and B-50 ml. To determine the efficiency of washing in relation to solution volume, washing was repeated three times. Concentrations of markers in samples were determined using flow cytometry. Mean concentrations of markers were significantly higher (P <0.001) in PF than in the first washing. We demonstrated a significant positive correlation between marker concentrations in PF and first washing (sOPN: r = 0.447, P = 0.048; sCD44-v6: r = 0.660, P = 0.002; sVCAM-1: r = 0.526, P = 0.017). When using a smaller solution volume for washing, significantly higher (sVCAM-1: 2.5-fold, P = 0.021; sOPN: 3-fold, P = 0.024) or equal (sCD44-v6) mean concentrations of tumor markers were obtained. Our work demonstrates for the first time that concentrations of sOPN, sCD44-v6 and sVCAM-1 in PF correlate with peritoneal washing in women with non-malignant pathology of the reproductive organs. This indicates that, for selected tumor markers, washing can replace PF when PF is absent. A standardized protocol for sampling PF and performing washing during laparoscopy was established.Keywords
This publication has 24 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial SpecimensCancer Prevention Research, 2011
- A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian CancerCancer Prevention Research, 2011
- Significance of Peritoneal Washing Cytopathology in Ovarian Carcinomas and Tumors of Low Malignant Potential: A Quality Control Study with Literature ReviewActa Cytologica, 2010
- Ovarian Cancer Development and MetastasisThe American Journal of Pathology, 2010
- Integrative Proteomic Analysis of Serum and Peritoneal Fluids Helps Identify Proteins that Are Up-Regulated in Serum of Women with Ovarian CancerPLOS ONE, 2010
- Cancer Screening: A Mathematical Model Relating Secreted Blood Biomarker Levels to Tumor SizesPLOS Medicine, 2008
- Diagnostic Markers for Early Detection of Ovarian CancerClinical Cancer Research, 2008
- Mechanisms of transcoelomic metastasis in ovarian cancerThe Lancet Oncology, 2006
- CHANGES IN VOLUME, TOTAL PROTEIN AND OVARIAN STEROID CONCENTRATIONS OF PERITONEAL FLUID THROUGHOUT THE HUMAN MENSTRUAL CYCLEJournal of Endocrinology, 1978